See All Slides - tctmd.com

Slides

Presentation TCT 2012

FDA's Perspective

Presenter: Ashwani Sastry

October 25, 2012

Presentation TCT 2012

AIDA STEMI MRI: Cardiac MRI Substudy from a Prospective, Randomized Trial of Intracoronary Abciximab in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Holger Thiele

October 25, 2012

Presentation TCT 2012

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Presenter: Antonio Colombo

October 25, 2012

Presentation TCT 2012

Patient Selection for PFO Closure: Who Should Be Treated Always, Sometimes, and Never?

Presenter: Jonathan Tobis

October 25, 2012

Presentation TCT 2012

The Misinterpretation of Clinical Trials: Common Errors and Case Examples

Presenter: Sanjay Kaul

October 25, 2012

Presentation TCT 2012

IVUS-Guided Reverse CART

Presenter: Yasushi Asakura

October 25, 2012

Presentation TCT 2012

Low-Profile Stent-Graft Delivery Systems Are Coming: What Do They Mean for the Field?

Presenter: Zvonimir Krajcer

October 25, 2012

Presentation TCT 2012

HCM Management: What Do the Guidelines Say?

Presenter: Bernard Gersh

October 25, 2012

Presentation TCT 2012

The Changing Nature of AAA Disease in the 21st Century

Presenter: Frank Criado

October 25, 2012

Presentation TCT 2012

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Presenter: Juan Granada

October 25, 2012

Advertisement

Slides

FDA's Perspective

AIDA STEMI MRI: Cardiac MRI Substudy from a Prospective, Randomized Trial of Intracoronary Abciximab in Patients with ST-Segment Elevation Myocardial Infarction

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Patient Selection for PFO Closure: Who Should Be Treated Always, Sometimes, and Never?

The Misinterpretation of Clinical Trials: Common Errors and Case Examples

IVUS-Guided Reverse CART

Low-Profile Stent-Graft Delivery Systems Are Coming: What Do They Mean for the Field?

HCM Management: What Do the Guidelines Say?

The Changing Nature of AAA Disease in the 21st Century

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content